Analysis

Judicial review aftermath: Pharmacy down but not out?

One month on from the judicial review, we examine the implications of the judgment and ask what happens now?

Time to get on with IT in pharmacy

Digitisation is a key priority for the NHS and a fundamental element of pharmacy’s new contractual arrangements in England

Getting to grips with the Quality Payments scheme

What is the new Quality Payments scheme and how do you secure the available funding? All the answers here

Health screening: Testing times

Technological advances mean that pharmacy has an increasingly important role to play in screening and diagnostics

Update: Special guidance

Recent RPS guidance puts the prescribing of specials back under the microscope

Antibiotic scripts fall for the first time in England

New PHE data has recorded a 4.3 per cent decline in antibiotic prescriptions in England

Thumbs up for pharmacy post-discharge service

Post-discharge consultations with community pharmacists can reduce the risk of hospital readmission

Enhancing skill mix in community pharmacy

A new report from Pharmacy Research UK has made recommendations for optimising the skill mix within community pharmacy

Biosimilars: new drugs on the block

Biosimilars are shaking up the $70bn global market for biological medicines

Patients still expect antibiotics for sore throats

Nearly half of UK adults have been prescribed antibiotics for a sore throat, shows new research

Survey reveals views on the future of healthcare

The British population is keen to embrace self care, new technology and personalised treatment to reduce NHS burdens, suggests a new survey

Pharmacies can help detect coeliac disease

An innovative project has shown that community pharmacies can help find patients with undiagnosed coeliac disease

Briefing: Where now for self-care?

The current regulatory environment undermines opportunities for self-care, says a recent report

Diabetes drugs cost approaches £1bn per year

The annual primary care prescribing cost of medicines for diabetes has reached £956.7 million

Thumbs up for pharmacy sore throat screening

Pharmacy screening for bacterial throat infections could help fight antibiotic overuse, shows a new study

What does Brexit mean for pharmacy?

Pharmacy organisations are trying to reassure stakeholders over Brexit, while seeking reassurances for themselves

Where’s the urgency with antimicrobial stewardship?

Some CCGs have still not fully implemented NICE antimicrobial stewardship guidance. Is diagnostic testing the answer?

Now is not the time to deprioritise MCA training

Could pharmacies decide to deprioritise medicine counter assistant training as funding cuts begin to bite?

Don’t waste pharmacy’s potential

The pharmacy cuts could hit the UK’s ability to meet the WHO’s mortality goals, according to a new report

Stress testing the profession: pharmacists struggling

New research suggests pharmacists are weighed down with the strain of coping with their workload and the stress of the job
Previous 1 2 3 4 5 Next

Latest

Dovonex is switched from POM to P

Dovonex Psoriasis Ointment (calcipotriol 50mcg/g) has been reclassified as a P medicine, the MHRA has announced

Pharmacists key to reducing polypharmacy in over-70s

Medication reviews by clinical pharmacists will reduce polypharmacy in the over-70s, new research suggests

Views

Have your say on ’Face to face’ report

By NPA head of communications, Stephen Fishwick. The NPA has released its ‘Face to face’ report and would like to yo...

Popular

New professional standards now in force

New standards for pharmacists and technicians, which emphasise person-centred professionalism, came into effect on May ...

PDA challenges GPhC’s revalidation proposals

The PDA pulls apart the GPhC’s proposed revalidation framework, saying it is actually referring to CPD

Aspirin may protect against breast cancer in diabetes

Long-term low-dose aspirin reduces the risk of breast cancer in women with diabetes